What is Satellos Bioscience Inc. Common Stock?
, a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 140.56M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.